Advance information improves user satisfaction with the levonorgestrel intrauterine system

被引:116
作者
Backman, T
Huhtala, S
Luoto, R
Tuominen, J
Rauramo, I
Koskenvuo, M
机构
[1] Turku Univ Hosp, Dept Obstet & Gynecol, FIN-20510 Turku N, Finland
[2] Univ Turku, Dep Biostat & Publ Hlth, Turku, Finland
[3] Leiras Clin Res, Turku, Finland
[4] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland
关键词
D O I
10.1016/S0029-7844(01)01764-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To evaluate parameters associated with and the impact of advance information given in a regular outpatient setting on user satisfaction with the levonorgestrel-releasing intrauterine system. METHODS: A questionnaire was sent to 23,885 women in Finland who had had a levonorgestrel intrauterine system inserted between 1990 and 1993. The number of returned questionnaires was 17,914 (response rate 75%). Cumulative logistic regression analysis was based on the five-grade scale of satisfaction as a dependent variable. RESULTS: Most users of the levonorgestrel-releasing intrauterine system (74%) were very or fairly satisfied with it, although over 70% of them had chosen it because of dissatisfaction with their previous method of contraception. User satisfaction increased with age and was associated with the amount of information about different symptoms (menstrual, greasiness of hair/skin, pregnancy, pelvic inflammatory disease, and missed periods) regardless of whether the symptom in question was actually experienced. The women who received information about the possibility of absence of menstruation were more satisfied than the less informed women (odds ratio 5.0, 95% confidence interval 4.1, 5.9). CONCLUSION: Information received at the insertion visit is strongly associated with increased user satisfaction among the users of the levonorgestrel intrauterine system. The association between high user satisfaction and advance information was strongest regarding the possibility of missing periods. (Obstet Gynecol 2002;99:608-13. (C) 2002 by the American College of Obstetricians and Gynecologists.).
引用
收藏
页码:608 / 613
页数:6
相关论文
共 30 条
  • [1] A long form of the skate IgX gene exhibits a striking resemblance to the new shark IgW and IgNARC genes
    Anderson, MK
    Strong, SJ
    Litman, RT
    Luer, CA
    Amemiya, CT
    Rast, JP
    Litman, GW
    [J]. IMMUNOGENETICS, 1999, 49 (01) : 56 - 67
  • [2] Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users
    Backman, T
    Huhtala, S
    Blom, T
    Luoto, R
    Rauramo, I
    Koskenvuo, M
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (03): : 335 - 339
  • [3] BAVEJA R, 1989, Contraception, V39, P37
  • [4] AN EVALUATION OF THE LEVONORGESTREL-RELEASING IUD - ITS ADVANTAGES AND DISADVANTAGES WHEN COMPARED TO THE COPPER-RELEASING IUDS
    CHI, IC
    [J]. CONTRACEPTION, 1991, 44 (06) : 573 - 588
  • [5] VAGINAL BLEEDING PATTERNS OF WOMEN USING DIFFERENT CONTRACEPTIVE METHODS (IMPLANTS, INJECTABLES, IUDS, ORAL PILLS) - AN INDIAN EXPERIENCE - AN ICMR TASK-FORCE STUDY
    DATEY, S
    GAUR, LN
    SAXENA, BN
    [J]. CONTRACEPTION, 1995, 51 (03) : 155 - 165
  • [6] The influence of type of information, somatization, and locus of control on attitude, knowledge, and compliance with respect to the triphasic oral contraceptive Tri-Minulet(R)
    Deijen, JB
    Kornaat, H
    [J]. CONTRACEPTION, 1997, 56 (01) : 31 - 41
  • [7] Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use
    den Tonkelaar, I
    Oddens, BJ
    [J]. CONTRACEPTION, 1999, 59 (06) : 357 - 362
  • [8] EVALUATION OF THE CLINICAL-PERFORMANCE OF A LEVONORGESTREL-RELEASING IUD, UP TO 7 YEARS OF USE, IN CAMPINAS, BRAZIL
    DIAZ, J
    FAUNDES, A
    DIAZ, M
    MARCHI, N
    [J]. CONTRACEPTION, 1993, 47 (02) : 169 - 175
  • [9] Low dose oral contraceptives and quality of life
    Egarter, C
    Topcuoglu, MA
    Imhof, M
    Huber, J
    [J]. CONTRACEPTION, 1999, 59 (05) : 287 - 291
  • [10] Norplant® consensus statement and background review
    Fraser, IS
    Tiitinen, A
    Affandi, B
    Brache, V
    Croxatto, HB
    Diaz, S
    Ginsburg, J
    Gu, SJ
    Holma, P
    Johansson, E
    Meirik, O
    Mishell, DR
    Nash, HA
    von Schoultz, B
    Sivin, I
    [J]. CONTRACEPTION, 1998, 57 (01) : 1 - 9